MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with T

Trospium

Trospium chloride 20mg tablets

Use with caution

Stability notes for Trospium chloride 20mg tablets

Store in an airtight container and protect from light.

Provenance

This compatibility recommendation is derived from Regurin 20mg tablets (Viatris UK Healthcare Ltd).

Suppliers (11) of Trospium chloride 20mg tablets
Regurin 20mg tablets (Necessity Supplies Ltd)
Regurin 20mg tablets (Viatris UK Healthcare Ltd)
Trospium chloride 20mg tablets (A A H Pharmaceuticals Ltd)
Trospium chloride 20mg tablets (Accord-UK Ltd)
Trospium chloride 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Trospium chloride 20mg tablets (Drugsrus Ltd)
Trospium chloride 20mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Trospium chloride 20mg tablets (Lexon (UK) Ltd)
Trospium chloride 20mg tablets (Necessity Supplies Ltd)
Trospium chloride 20mg tablets (Perennial Pharma Ltd)
Trospium chloride 20mg tablets (Sigma Pharmaceuticals Plc)

Trospium chloride 60mg modified-release capsules

Compatible

Stability notes for Trospium chloride 60mg modified-release capsules

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Regurin XL 60mg capsules (Viatris UK Healthcare Ltd).

Suppliers (5) of Trospium chloride 60mg modified-release capsules
Regurin XL 60mg capsules (CST Pharma Ltd)
Regurin XL 60mg capsules (Lexon (UK) Ltd)
Regurin XL 60mg capsules (Necessity Supplies Ltd)
Regurin XL 60mg capsules (Pilsco Ltd)
Regurin XL 60mg capsules (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.